Alternatives to Pangea Biomed

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Harnessing genetic data for digital insights in rare and germline disorders.

AI platform for accelerating novel peptide therapeutic discovery and development.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.